Director/PDMR Shareholding

RNS Number : 9899I
Melrose PLC
01 August 2012
 



1 August 2012

 

Notification of transactions of persons discharging managerial responsibility and their connected persons in accordance with DTR 3.1.4R(1)(a).

 

Melrose PLC

("Melrose")

 

Melrose was notified today, in accordance with DTR 3.1.2R, that today, the transactions set out below occurred in London in connection with new ordinary shares of 14/55 pence each in the share capital of Melrose, (each an "Ordinary Share"). Each of the persons identified below is a "person discharging managerial responsibility", as such term is defined in the Disclosure and Transparency Rules (the "DTRs"), with the exception of Harris & Sheldon Investments Limited, which is a "connected person" (as such term is defined in the DTRs) in respect of Christopher Miller:

 

·      Christopher Miller, Executive Chairman, acquired 4,256,039 Ordinary Shares at a price of 142 pence per Ordinary Share pursuant to the 2 for 1 rights issue which commenced on 17 July 2012 (the "Rights Issue"). Immediately following such acquisition, Mr. Miller held 10,175,344 Ordinary Shares (amounting to 0.80% of the Enlarged Share Capital1);

 

·      Harris & Sheldon Investments Limited, acquired 1,839,286 Ordinary Shares at a price of 142 pence per Ordinary Share pursuant to the Rights Issue. Immediately following such acquisition, Harris & Sheldon Investments Limited held 4,000,000 Ordinary Shares (amounting to 0.32% of the Enlarged Share Capital);

 

·      David Roper, Executive Vice-Chairman, acquired 4,008,963 Ordinary Shares at a price of 142 pence per Ordinary Share pursuant to the Rights Issue. Immediately following such acquisition, Mr. Roper held 9,584,633 Ordinary Shares (amounting to 0.76% of the Enlarged Share Capital);

 

·      Simon Peckham, Chief Executive, acquired 4,042,188 Ordinary Shares at a price of 142 pence per Ordinary Share pursuant to the Rights Issue. Immediately following such acquisition, Mr. Peckham held 9,664,068 Ordinary Shares (amounting to 0.76% of the Enlarged Share Capital);

 

·      Geoffrey Martin, Group Finance Director, acquired 1,990,461 Ordinary Shares at a price of 142 pence per Ordinary Share pursuant to the Rights Issue. Immediately following such acquisition, Mr. Martin held 4,758,797 Ordinary Shares (amounting to 0.38% of the Enlarged Share Capital);

 

·      Miles Templeman, Senior Non-Executive Director, acquired 319,012 Ordinary Shares at a price of 142 pence per Ordinary Share pursuant to the Rights Issue. Immediately following such acquisition, Mr. Templeman held 632,343 Ordinary Shares (amounting to 0.05% of the Enlarged Share Capital);

 

·      Perry Crosthwaite, Non-Executive Director, acquired 119,252 Ordinary Shares at a price of 142 pence per Ordinary Share pursuant to the Rights Issue. Immediately following such acquisition, Mr. Crosthwaite held 222,377 Ordinary Shares (amounting to 0.02% of the Enlarged Share Capital);

 

·      John Grant, Non-Executive Director, acquired 149,970 Ordinary Shares at a price of 142 pence per Ordinary Share pursuant to the Rights Issue. Immediately following such acquisition, Mr. Grant held 295,817 Ordinary Shares (amounting to 0.02% of the Enlarged Share Capital); and

 

·      Justin Dowley, Non-Executive Director, acquired 276,000 Ordinary Shares at a price of 142 pence per Ordinary Share pursuant to the Rights Issue. Immediately following such acquisition, Mr. Dowley held 414,000 Ordinary Shares (amounting to 0.03% of the Enlarged Share Capital).

 

-ends-

 

1 As such term is defined in the shareholder circular published by Melrose on 29 June 2012.

Enquiries:

M:Communications

Nick Miles/Ann-marie Wilkinson/Andrew Benbow                                                                         +44 (0)207 920 2330

 

This announcement is for information purposes only and shall not constitute an offer to buy, sell, issue or subscribe for, or the solicitation of an offer to buy, sell, issue, or subscribe for, any securities in Melrose or any other entity. No securities of Melrose have been or will be registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration thereunder.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKMGFNLMRGZZM
UK 100